Items where authors include "Worm, M."

Article

Kosloski, M.P. orcid.org/0000-0002-6642-2439, Guttman‐Yassky, E. orcid.org/0000-0002-9363-324X, Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (13 more authors) (2024) Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials. Clinical and Translational Science, 17 (8). e13874. ISSN 1752-8054

Zuberbier, T. orcid.org/0000-0002-1466-8875, Abdul Latiff, A., Aggelidis, X. orcid.org/0000-0003-1715-3022 et al. (105 more authors) (2023) A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative. Clinical and Translational Allergy, 13 (9). e12299. ISSN 2045-7022

Zuberbier, T. orcid.org/0000-0002-1466-8875, Beck, L.A., Bedbrook, A. et al. (12 more authors) (2023) Developing integrated care pathways for atopic dermatitis—challenges and unmet needs. Clinical and Translational Allergy, 13 (3). e12236. ISSN 2045-7022

Ring, J., Worm, M., Wollenberg, A. et al. (35 more authors) (2021) Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35 (6). e362-e365. ISSN 0926-9959

Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E. et al. (19 more authors) (2021) Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2). British Journal of Dermatology, 184 (3). pp. 437-449. ISSN 0007-0963

Simpson, E.L., Bieber, T., Guttman-Yassky, E. et al. (23 more authors) (2016) Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. The New England Journal of Medicine. ISSN 0028-4793